(RTOG 0534) A Phase III Trial Of Short Term Androgen Deprivation With Pelvic Lymph Node Or Prostate Bed Only Radiotherapy (Spport) In Prostate Cancer Patients With A Rising PSA After Radical Prostatectomy
Description: 

The purpose of this study is to compare the effects that radiation therapy, hormone therapy or the combination of both have on participants with prostate cancer. There are 3 treatment groups (also referred to as arms) that the patient may be randomized (put into a group by chance) to in this study:
*Patients who receive radiation therapy to the prostate bed only;
*Patients who receive hormone therapy for 4 to 6 months plus radiation therapy to the prostate bed;
*Patients who receive hormone therapy for 4 to 6 months plus radiation therapy to the prostate bed and to the pelvic lymph nodes

Study Number: 

NCG 126608

Phase: 
III
Principal Investigator: 
ClinicalTrials.Gov ID: 
NCT00567580

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail askrpci@roswellpark.org.